IMP
Process View
acylglycerol biosynthetic process
The chemical reactions and pathways resulting in the formation of acylglycerol, any mono-, di- or triester of glycerol with (one or more) fatty acids.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "acylglycerol biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| APOE | apolipoprotein E | 0.881 | ||
| RPL18A | ribosomal protein L18a | 0.757 | ||
| ANG | angiogenin, ribonuclease, RNase A family, 5 | 0.521 | ||
| RNASE4 | ribonuclease, RNase A family, 4 | 0.498 | Human | |
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.442 | ||
| CFH | complement factor H | 0.295 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.216 | ||
| CCNE1 | cyclin E1 | 0.161 | ||
| CCDC6 | coiled-coil domain containing 6 | 0.130 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.085 | ||
| CTDNEP1 | CTD nuclear envelope phosphatase 1 | 0.078 | ||
| MED15 | mediator complex subunit 15 | 0.069 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.053 | ||
| HP | haptoglobin | 0.049 | ||
| TMEM188 | transmembrane protein 188 | 0.046 | ||
| MSTO1 | misato homolog 1 (Drosophila) | 0.043 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.042 | ||
| PCSK9 | proprotein convertase subtilisin/kexin type 9 | 0.039 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.037 | ||
| MDK | midkine (neurite growth-promoting factor 2) | 0.033 | ||
| CFB | complement factor B | 0.031 | ||
| CFI | complement factor I | 0.029 | ||
| CREBBP | CREB binding protein | 0.029 | ||
| RNH1 | ribonuclease/angiogenin inhibitor 1 | 0.024 | ||
| APOC1 | apolipoprotein C-I | 0.023 | ||
| SHPRH | SNF2 histone linker PHD RING helicase | 0.022 | ||
| MED13L | mediator complex subunit 13-like | 0.020 | ||
| INSIG1 | insulin induced gene 1 | 0.019 | ||
| NUCB1 | nucleobindin 1 | 0.018 | ||
| HIC1 | hypermethylated in cancer 1 | 0.017 | ||
| AR | androgen receptor | 0.017 | ||
| MED25 | mediator complex subunit 25 | 0.016 | ||
| FBXW2 | F-box and WD repeat domain containing 2 | 0.016 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.015 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.014 | ||
| DHCR7 | 7-dehydrocholesterol reductase | 0.014 | ||
| SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 0.013 | ||
| UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.012 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.012 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.011 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.011 | ||
| TRIM11 | tripartite motif containing 11 | 0.011 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.011 | ||
| TTR | transthyretin | 0.010 | ||
| AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) | 0.010 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.010 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.010 |